ABG Analytics logo
Get updates

Celgene Corp (NASDAQ: CELG)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 11/15/2019
Closing price: 110.02
Support price level: $98.56
Resistance price level: N/A
Relative strength index (14-day RSI) 81.9
Beta 1.15
  • CELG is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • With a 58.0 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.

  • Volatility is forecast to rise over the next month.

  • With RSI > 70, CELG is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$59.21 $110.41 99.4%
200 day 50 day 20 day 10 day
$95.29 $102.58 $107.54 $109.23
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
30.7% 18.1% 16.4% 24.3%
There is an estimated 5% probability that the stock price of Celgene Corp will fall by more than:
  • 4.5% in the next week.

  • 13.8% in the next month.

  • 58.9% in the next year.